Emory Patent Group
Virus-like particles comprising chimeric human immunodeficiency virus (HIV)/mouse mammary tumor virus (MMTV) envelopes
Embodiments of the present disclosure encompasses virus-like particles, methods of making virus-like particles, including expression vectors, wherein the virus-like particles may comprise enhanced levels of capsid-bound a chimeric HN-Env polypeptide compared to VLPs derived from unmodified HIV-env polypeptides. Embodiments of the virus-like particle may have Env-specific epitopes exposed on the outer surface thereof. In one embodiment, the Env-specific epitopes exposed on the outer surface of the virus-like particle may specifically bind with an anti-HIV-Env specific antibody. Embodiments of the disclosure further includes methods of generating an antibody specific to an epitope of an HIV-Env polypeptide, comprising delivering to an animal or a human an effective amount of a suspension of virus-like particles comprising a chimeric HIV-Eny polypeptide, thereby inducing the formation of an antibody specific to an epitope of an HIV-1 eny polypeptide.
Novavax, Inc. Emory University The UAB Research Foundation
C C C C C C A A C C C A C C C C C
C12Y C12N C07K C12N C12N C07K A61K A61K C12N C07K C12N A61K C12N C07K C12N C12N C12N
inventional additional additional additional additional inventional inventional additional inventional additional additional inventional additional inventional additional additional additional
Beatrice Weimin Peter Gale Richard W. Baozhong
Hahn Liu Pushko Smith Compans Wang